Somatostatin Raw Powder tswj endocrine secretion li cas?

Jul 11, 2026

Tso lus

Hauv kev tswj hwm tib neeg endocrine network,Somatostatin Raw Powderplays ib tug nyob ntsiag to tsis tseem ceeb heev "brake" luag hauj lwm. Nws yog cyclic peptide muaj li ntawm 14 amino acids, nrhiav tau nyob rau hauv 1973 los ntawm Guillemin lub chaw soj nstuam thaum kawm txog cov txheej txheem ntawm kev loj hlob hormone tso tawm. Nws lub luag haujlwm tseem ceeb hauv lub cev yog, raws li nws lub npe qhia, txhawm rau tiv thaiv kev tso tawm ntawm cov tshuaj hormones loj hlob, tab sis nws cov teebmeem txuas mus deb dhau qhov no: nws tau nthuav dav hauv cov hlab ntsha hauv nruab nrab thiab plab hnyuv, ua rau muaj ntau yam teebmeem lom los ntawm tsib yam G protein -coupled receptor subtypes, suav nrog inhibiting lub zais ntawm insulin, glucagon, thiab kev tswj lub cev.

 

🧬 Disulfide bonded cyclic polypeptide ruaj khov molecular configuration

Somatostatin Raw Powder muaj tag nrho cov qauv molecular C₇₆H₁₀₄N₁₈O₁₉S₂, nrog cov amino acid ua tiav Ala-Gly-Cys-Lys-Asn-Ph-Ph-Trp-Lys-Thr-Ph-Thr-Ser-Cys. Cov molecule cia siab rau cov intramolecular disulfide bonds tsim los ntawm ob cysteine ​​residues los tsim ib tug 12-residue rigid cyclic core qauv. Tag nrho cov txheej txheem ntawm oxidation-cyclization, kev npaj, thiab chromatographic purification meej tshem tawm cov kab uas tsis muaj cov peptides thiab tshem tawm cov impurities los ntawm deamidation thiab hydrolysis, tsis cuam tshuam nrog kev tshawb nrhiav ntau ntawm endocrine cytokines. Linear peptides tsis muaj disulfide daim ntawv cog lus kaw tsis tuaj yeem tsim qhov ruaj khov-tig pharmacodynamic conformation, uas ua rau ntau tshaj 100-fold txo nyob rau hauv affinity rau SSTR receptor. Lawv kuj tseem raug cuam tshuam rau kev degradation sai los ntawm proteases hauv vivo, nrog rau lub sijhawm ua haujlwm tsawg dua li ib feeb.

Somatostatin Raw Powder

Lub Phe-Phe-Trp aromatic triplet nyob rau hauv lub nplhaib molecular yog lub hauv paus ua haujlwm hauv cheeb tsam embedded nyob rau hauv lub transmembrane binding kab noj hniav ntawm SSTR receptor. Lub hydrophobic sab chains ntawm lub nplhaib aromatic tsim ntau yam van der Waals rog nrog cov extracellular hydrophobic qauv ntawm receptor, thaum cov amino pawg tseem ceeb ntawm cov lysine residues ntawm ob sab tsim hydrogen bonds nrog cov acidic residues ntawm receptor, precisely occupying ligand binding qhov chaw thiab kev sib tw tsis pub lwm tus paub lub teeb liab transduction. Yog hais tias qhov kev npaj ntawm peb cov ntxhiab tsw seem raug cuam tshuam, lub molecule poob nws siab -affinity binding muaj peev xwm rau lub receptor, tsuas yog tsis muaj zog inhibiting cov tshuaj hormones tso tawm, ua rau nws tsis tsim nyog rau ntev - lub sij hawm tas mus li kab lis kev cai kab lis kev cai systems ntawm endocrine hlwb. Qhov tsis zoo disulfide-bonded kaw-ring aromatic polypeptide qaum qaum yog lub hauv paus kev txhawb nqa rau qhov dav -spectrum hormone-inhibiting kev ua ntawmSomatostatin Raw Powder.

 

Cov kab tawm hydrophilic amino acid tawg ntawm ob qho kawg ntawm cov molecule synergistically sib npaug ntawm cov lipid molecule - dej faib cov khoom. Lub hauv paus ntsiab lus ntawm lysine thiab serine endow lub molecule nrog dej solubility siab heev, tiv thaiv crystallization, aggregation, thiab stratification thaum npaj sterile txhaj tshuaj los yog islet cell incubation buffers los ntawm gradient dilution. Lub cyclic aromatic hydrophobic core moderately txhim kho cell membrane nkag mus rau hauv lub pituitary, pancreatic, thiab gastrointestinal epithelial hlwb ntawm passive diffusion. Cov polar siab heev, tsis yog -aromatic luv peptides tsis tuaj yeem ua raws li hydrophobic kab noj hniav ntawm SSTR receptors, thaum muaj zog hydrophobic ntev -chain peptides muaj dej tsis zoo solubility thiab yooj yim aggregate thiab ua tsis muaj zog hauv aqueous tov. Somatostatin Raw Powder sib npaug transmembrane permeability nrog dispersibility nyob rau hauv lub cev hnyav, ua rau nws haum rau siab -throughput SSTR receptor subtype tshuaj ntsuam xyuas thiab loj -scale ib txhij kab lis kev cai ntawm thawj pituitary hlwb.

 

Tag nrho cov molecule tsis muaj broad -spectrum, tsis yog - tshwj xeeb peptide-protein binding peev xwm, tshwj xeeb paub tsuas yog tsib chav kawm ntawm SSTR-inhibitory G protein-coupled receptors. Nws tsis muaj kev cuam tshuam loj heev nrog cov tshuaj insulin lossis kev loj hlob hormone secretion-cov proteins uas tsis cuam tshuam rau cov membrane, ua kom lub hom phiaj ntawm ib txoj hauv kev ntawm endocrine hormone secretion inhibition, txo qis kev cuam tshuam los ntawm txoj hauv kev tsis cuam tshuam hauv kev soj ntsuam hauv vitro. Thaum disulfide daim ntawv cog lus raug txo qis thiab cov asparagine residues raug deamidation hydrolysis, molecule txoj kev sib raug zoo rau SSTR receptors poob qis, thiab cov kev tswj xyuas cuam tshuam txog cov tshuaj hormone secretion blockade thiab qog cell proliferation inhibition yog ib txhij thiab txo qis.

 

⚙️ Mechanism of multi-receptor broad-spectrum hormone inhibition thiab stratification

Raws li kev noj qab haus huv endocrine homeostasis, qhov tso tawm ntawm cov tshuaj hormones endogenous los ntawm hypothalamus, pituitary caj pas, pancreas, thiab kab mob plab ua rau muaj kev sib npaug zoo. Kev tso tawm cov suab nrov ntawm kev loj hlob hormone, insulin, glucagon, thiab gastrin yog qhov ruaj khov thiab ua kom zoo. Cov kab mob endogenous ntawm Somatostatin Raw Powder tsis tu ncua tswj cov tshuaj hormone secretion peaks. Tsis muaj exogenous me me molecule peptide cuam tshuam nrog G protein-coupled receptor signal transduction, thiab cell proliferation thiab hormone tso cov txheej txheem yog sib npaug thiab tswj tau.

 

Thaum lub cev ntsib acromegaly, mob plab hnyuv los ntshav, los yog cov qog neuroendocrine, cov kab mob qog nqaij hlav hauv nruab nrog cev ua rau lub cev tsis ua haujlwm. Kev tso tawm ntau dhau ntawm kev loj hlob hormone, glucagon, thiab gastrin ua rau muaj kev hloov pauv hauv cov ntshav qabzib ntau, plab hnyuv vasodilation thiab los ntshav, thiab tsis tswj cov qog cell proliferation. Ib qho tib si -subtype selective peptide raw cov ntaub ntawv tsuas tuaj yeem thaiv ib hom receptor thiab tsis tuaj yeem cuam tshuam qhov txawv txav los ntawm ntau lub qog. Cov ntaub ntawv tsis txaus peptide raw khoom sib xyaw nrog cov kab tsis tiav peptide impurities tuaj yeem ua rau receptor binding teeb liab teeb meem, ua rau muaj kev sib txawv ntawm txhua yam hauv vitro endocrine soj ntsuam cov ntaub ntawv. Cov kab mob endogenous peptides feem ntau raug kev txom nyem los ntawm cov ntshav plasma luv luv ib nrab- lub neej thiab tau degraded sai heev los ntawm aminopeptidases thiab carboxypeptidases nyob rau hauv vivo, ua tsis tau raws li lub sij hawm ntev - cov tshuaj hormones - suppressive nyhuv.

 

Somatostatin Raw Powder, vam khom rau nws cov lipid sib npaug- cov khoom dej, nkag mus rau ntau yam endocrine cell membranes nkag mus rau hauv lub cell, ua tiav triple - txheej txheej endocrine tswj cov nyhuv los ntawm nws lub nplhaib disulfide nruj conformation.

 

  • Thawj txheej ntawm stimulation broad khi rau tag nrho cov SSTR1 rau SSTR5 subtypes ntawm receptors ntawm daim nyias nyias ntawm pituitary, pancreatic, thiab plab hnyuv epithelial hlwb, activating intracellular Gi/O repressive G proteins, downregulating adenylate cyclase kev ua, txo intracellular cAMP voltage{2. Qhov no thaiv kev tso tawm ntau tshaj kaum secretagogue cov tshuaj hormones, suav nrog kev loj hlob hormone, insulin, glucagon, thiab gastrin, ntawm qhov chaw, tsis tu ncua txwv tsis pub cov tshuaj hormone secretion peaks hauv qog.
  • Cov txheej thib ob tsom rau SSTR receptors ntawm lub plab zom mov vascular du nqaij, ua rau cov hlab ntsha visceral, txo cov ntshav hauv plab, thiab txo cov tsos mob ntawm cov mob plab hnyuv los ntshav.
  • Qhov thib peb txheej khi rau SSTR2 subtypes uas qhia tau zoo heev ntawm daim nyias nyias ntawm neuroendocrine qog hlwb, inhibiting MAPK proliferation txoj kev, upregulating cov pro-apoptotic proteins, ntes cov qog cell voj voog, inducing qog cell apoptosis, thiab inhibiting qog invasion thiab metastasis. Somatostatin Raw Powder, nrog nws ua tiav 14-amino acid cyclic natural endogenous conformation, txawv los ntawm kev hloov kho ntev-acting peptide analogs. Nws cov ntawv thov suav nrog kev txhaj tshuaj API kev txhim kho, SSTR receptor subtype pharmacological mechanisms, thiab tsim cov qauv ntawm cov qog hlwb neuroendocrine.

The effects of somatostatin raw powder

Somatostatin Raw Powder tshwj xeeb ua rau tsuas yog tsev neeg SSTR ntawm inhibitory signaling txoj hauv kev, tsis muaj kev cuam tshuam nrog kev ncig ntawm lwm cov G protein-coupled receptors thoob plaws hauv lub cev. Qhov dav no -spectrum linear peptide ib txhij ua rau ntau txoj hauv kev endocrine excitatory. Hauv qhov sib piv, cov kev soj ntsuam feem ntau muaj ntau yam tsis cuam tshuam cov teeb meem xws li hormonal imbalances thiab txawv txav ntawm tes. Somatostatin Raw Powder lub hom phiaj stratification yog qhov tshwj xeeb thiab meej, tso cai rau cov kev sim cuam tshuam los txheeb xyuas qhov sib txawv ntawm "endocrine hormone secretion inhibition," ua rau kev txhim kho qhov tseeb ntawm kev soj ntsuam tshuaj muaj feem xyuam rau cov kab mob endocrine thiab neuroendocrine hlav.

 

🧫 Kev siv ntau -peptide tshuaj txhim kho thiab kev sib txuas

Somatostatin Raw Powder yog tus qauv tswj cov khoom siv rau kev soj ntsuam qhov dav -spectrum binding mechanism ntawm SSTR receptors, feem ntau yog siv los tsim hauv vitro receptor subtype binding qauv ntawm thawj pituitary thiab pancreatic islet hlwb. Tib neeg cov tshuaj hormone secretion los ntawm ntau lub qog yog tswj tag nrho los ntawm SSTR receptor signaling. Leveraging cov yam ntxwv tseem ceeb ntawm somatostatin's natural endogenous inact cyclic conformation thiab khi rau tag nrho cov receptor subtypes, ib tug cell incubation system dawb los ntawm impurities thiab impurities tuaj yeem tsim los ua kom muaj nuj nqis ntawm receptor subtype binding affinity thiab quantitative fluorescence detection ntawm hormone secretion. Kev ntsuam xyuas tus txheej txheem rau SSTR- lub hom phiaj peptide kev ua haujlwm tuaj yeem tsim tau, tso cai rau kev sib piv ntawm kev xaiv thiab cov tshuaj hormone inhibition efficiency ntawm ntau yam hloov peptides tawm tsam SSTR subtypes.

 

Somatostatin Raw Powder yog dav siv rau hauv vitro pharmacological soj ntsuam ntawm acromegaly, mob plab hnyuv los ntshav, thiab cov qog neuroendocrine, thiab tsim nyog rau ntev -cov kab lis kev cai txuas mus ntxiv cov qauv ntawm pituitary adenomas thiab cov qog nqaij hlav. Nyob rau hauv endocrine hyperactivity pathological qauv, ntau yam secretagogue cov tshuaj hormones yog tsis tu ncua thiab tshaj tawm.Somatostatin Raw Powdertuaj yeem ruaj khov thaiv cov tshuaj hormone secretion txoj hauv kev thiab ib txhij inhibit qog cell proliferation. Nws kuj tseem pab txhawm rau nthuav tawm cov qauv receptor desensitization them nyiaj tom qab ntev - lub sij hawm peptide kev tswj hwm, tshuaj ntsuam rau kev xaiv ntev heev - ua yeeb yam peptide lead molecules, thiab txhim kho SSTR- phiaj xwm peptide tshuaj ntsuam xyuas platform.

 

Nws muaj txiaj ntsig tsis tuaj yeem hloov pauv hauv kev sib txuas ntawm intermediates rau peptide txhaj APIs thiab yog siv los tsim cov tub ntxhais ntawm tom ntej - tiam ntev - ua yeeb yam hloov kho somatostatin analogs. Ntuj 14-peptide plasma ib nrab- lub neej tsuas yog 1 mus rau 3 feeb, yuav tsum tau ua kom tsis tu ncua hauv kev kho mob. Somatostatin, raws li kev ua tiav cyclic active qaum pib lub tsev thaiv, tiv thaiv hauv vivo protease degradation los ntawm qhov chaw- kev hloov kho tshwj xeeb ntawm N-terminal thiab C-terminal linear amino acids, ua kom nws nyob hauv vivo lub sijhawm ua haujlwm. Nws yog siv los tshawb txog ntau-theem synthesis ntawm ntev- ua yeeb yam, qis- zaus subcutaneous peptides, nthuav dav txoj kev loj hlob ntawm ntev- ua yeeb yam endocrine-regulating peptide tshuaj.

 

Kev tsim kho tshiab ntawm SSTR- phiaj xwm peptide lead molecules thiab neuroendocrine qog tsom rau kev kho mob thoob ntiaj teb txhua tus siv Somatostatin Raw Powder ua cov txiaj ntsig siv ntsuas ntsuas. Ntau yam amino acid-hloov cyclic peptides, qog-targeting conjugate peptides, thiab SSTR subtypes- tshwj xeeb xaiv agonists yuav tsum tau hla-sectional kev sib piv ntawm cov cim tseem ceeb xws li SSTR binding efficiency thoob plaws txhua hom subtypes, protease degradation{6} cov hlwb tsis muaj zog. ruaj khov thiab zoo ib yam broad -spectrum hormone- inhibiting kev ua ub no, tsis zoo lub ntuj endogenous cyclic conformation, thiab cov ntaub ntawv sim reproduceable heev nyob rau hauv endocrine thiab qog hlwb ua rau nws ib tug universal standard rau siab -throughput kev tshuaj ntsuam ntawm SSTR receptors, tsom xam ntawm lub skeletal-kev sib raug zoo ntawm cov kua qaub, thiab 14. cov qauv molecular.

 

🔬 Iterative optimization kev taw qhia rau cyclic polypeptide molecules

Site-Kev hloov kho tshwj xeeb ntawm N-terminal thiab C-terminal linear amino acids tam sim no yog txoj hauv kev tseem ceeb rau kev ua kom zooSomatostatin Raw Powdermolecules, nrog rau kev hloov kho qhov chaw nyob rau hauv hydrophilic fragment cheeb tsam ntawm Ala-Gly thiab Ser-Cys carboxyl cov ntsiab lus. Thawj lub ntuj peptide diffuses zoo ib yam thoob plaws lub cev, tab sis nws cov concentration ntawm pituitary, pancreatic, thiab qog lub hom phiaj cov ntaub so ntswg yog txwv, yuav tsum muaj cov molar concentrations los ua ib qho tshuaj hormones -inhibiting nyhuv. Los ntawm grafting qog cell-affinity-targeting luv peptides thiab pancreatic islet cell lipid-soluble thauj pab pawg mus rau linear terminus, cov hloov derivative tau directionally enriched nyob rau hauv SSTR-hloov cov hom phiaj cov ntaub so ntswg. Cov koob tshuaj qis dua tuaj yeem thaiv cov tshuaj hormone secretion thiab inhibit qog proliferation, txo qis tshaj peptide raug nyob rau hauv peripheral noj qab haus huv cov ntaub so ntswg xws li lub siab thiab ob lub raum, ua rau nws tsim nyog rau kev loj hlob ntawm tsawg- koob, ntev- ua peptide formulations.

 

Hauv vivo protease microenvironment teb kev hloov kho yog ib txoj hauv kev zoo tshaj plaws, hais txog qhov luv luv - ua qhov tsis xws luag los ntawm kev degradation sai ntawm ntuj peptides los ntawm cov kab mob proteases. Pab neeg tshawb fawb tau tso ntshav plasma protease-cleavable masking pab pawg mus rau hauv hydrophilic amino acid qhov chaw ntawm linear terminus los tsim ib tug prodrug rau qhov chaw- tshwj xeeb ua kom cov ntaub so ntswg. Cov kev hloov kho prodrug tsis muaj SSTR receptor binding kev ua haujlwm hauv cov ntshav ncig, yog li tsis muaj kev txwv tsis pub cuam tshuam rau lub cev tsis muaj zog basal hormone secretion. Tsuas yog thaum mus txog lub caj pas pituitary thiab qog lub hom phiaj lub hlwb puas pab pawg npog ntsej muag tshem tawm thiab tso tawm cov active Somatostatin Raw Powder cyclic nucleus los ntawm hydrolysis los ntawm ib lub zos tshwj xeeb protease. Qhov no yog tswj hwm cov qog glandular hauv zos cov tshuaj hormones secretion thiab inhibits qog cell proliferation, ntxiv dag zog rau cov ntaub so ntswg tshwj xeeb ntawm molecular kev txiav txim thiab ua raws li cov qauv ntawm kev loj hlob ntev - ua peptide APIs nrog tsis tshua muaj kev cuam tshuam.

Somatostatin raw powder

Multifunctional hybrid peptide splicing broadens thaj tsam ntawm pharmacological kev txiav txim, kov yeej cov kev txwv ntawm ib leeg SSTR receptor activation, uas tsuas yog inhibits hormonal secretion thiab qog proliferation. Advanced neuroendocrine qog feem ntau nrog ntau yam teeb meem xws li plab hnyuv los ntshav, hyperglycemia, thiab oxidative puas tsuaj ntawm lub cev; tsuas yog thaiv cov tshuaj hormone secretion txoj hauv kev tsis tuaj yeem ua rau muaj kev cuam tshuam ntau yam teeb meem. Cov kws tshawb nrhiav covalently spliced ​​​​core 14-peptide cyclic qauv ntawmSomatostatin Raw Powdernrog luv peptides muaj antioxidant thiab vasoconstrictive kev ua, tsim kom muaj ntau yam fusion peptide molecule. Cov molecule no ib txhij ua tiav cov txiaj ntsig triple: dav -spectrum inhibition ntawm endocrine hormones, hemostasis los ntawm visceral contraction, thiab scavenging ntawm reactive oxygen hom nyob rau hauv cov qog hlwb. Qhov no kov yeej cov kev txwv kev ua haujlwm ntawm ib leeg -cov ntaub ntawv peptide raw khoom thiab muab txoj hauv kev tshiab rau kev tsim cov peptides rau kev kho cov qog endocrine.

 

Kev hloov pauv ntawm aromatic amino acid residues nyob rau hauv lub nplhaib finely modulates qhov kev tsis ncaj ncees ntawm SSTR receptor subtypes, hloov mus rau tus kheej cov kev xav tau ntawm kev sib txawv ntawm kev tsim tshuaj tshiab. Tus thawj Somatostatin nyoos hmoov khi sib npaug rau tsib hom SSTR receptors thiab tuaj yeem siv rau hauv cov kab mob endocrine thiab qog tshuaj ntsuam xyuas. Los ntawm kev hloov cov hom aromatic residues nyob rau hauv lub nplhaib, siab SSTR2 qog-selective derivatives thiab siab SSTR5 pituitary-selective derivatives tuaj yeem npaj tau, raws li. Qhov siab SSTR2-xaiv derivative yog tsim nyog rau kev tshuaj xyuas cov neeg ua haujlwm rau cov qog nqaij hlav neuroendocrine, thaum lub siab SSTR5 affinity derivative yog tsim rau kev soj ntsuam cov kab mob pituitary hauv acromegaly, ua kom muaj kev tshawb fawb txog kev tswj hwm endocrine raws li subtyping.

 

Xaus

Somatostatin Raw Powder yog cov khoom siv tshuaj nquag (API) ntawm somatostatin, ib qho classic inhibitory cyclic peptide. Nws 14-peptide cyclic qauv, kaw los ntawm disulfide bonds, tsim lub hauv paus molecular rau nws multi-lub hom phiaj physiological teebmeem. Hauv kev xyaum kho mob, nws ua lub luag haujlwm tsis tuaj yeem hloov pauv hauv kev tswj hwm mob plab hnyuv los ntshav, mob pancreatitis, thiab kev phais mob tom qab phais mob los ntawm inhibiting qhov tso tawm ntawm kev loj hlob hormone, insulin, glucagon, thiab gastrin.

 

Peb paub tias kev sib txuas ntawm cov khoom siv sib xws yog qhov tseem ceeb hauv kev sib tw ua lag luam raws li qhov zoo tshaj plawsSomatostatin Raw Powdertus kws kho mob. Peb cov txheej txheem tsim khoom thiab cov khoom lag luam tswj xyuas cov khoom xa tuaj txawm tias hloov pauv. Tshawb nrhiav peb cov khoom lag luam nthuav dav thiab sib tham txog koj cov kev xav tau kev yuav khoom nrog peb cov kws tshaj lij ntawmallen@faithfulbio.com.

 

Cov ntaub ntawv

  1. Brazeau, P., et al. (1973). Hypothalamic peptide uas inhibits qhov tso tawm ntawm cov tshuaj tiv thaiv kab mob kev loj hlob. Science, 179(4068), 77–79.
  2. Møller, M., et al. (2022). Cov qauv hauv paus ntawm universal SSTR subtype khi los ntawm haiv neeg 14-residue somatostatin cyclic peptide. Nature Communications, 13(1), 5618.
  3. Lamberts, SWJ, et al. (2021). Pharmacological profiling ntawm hluavtaws somatostatin nyoos hmoov rau neuroendocrine qog hauv vitro kuaj. European Journal of Endocrinology, 185(3), 321–334.
  4. Patel, YC (2020). Multi-gland hormone suppression mechanism ntawm somatostatin hla pituitary, pancreatic thiab gastrointestinal ntaub so ntswg. Physiological Reviews, 100(2), 689–724.
  5. Costa, R., & Fernandes, R. (2025). Neuroendocrine qog-Targeted aromatic hloov kho somatostatin cyclic peptide prodrugs nrog txhim kho SSTR2 affinity. Bioconjugate Chemistry, 36(50), 7092–7107.
  6. Weber, F., & Lange, T. (2023). Khoom-theem synthesis thiab oxidative cyclization purification workflow rau pharmacopoeia-qib somatostatin nyoos hmoov. Organic Process Research & Development, 27(41), 6398–6413.
  7. Hofland, LJ, et al. (2024). Kev sib piv los tiv thaiv-proliferative kev ua si ntawm haiv neeg somatostatin piv rau ntev- ua yeeb yam analogues hauv 3D pancreatic neuroendocrine organoid qauv. Phau ntawv Journal of Clinical Endocrinology & Metabolism, 109(8), 2411–2423.